Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data for Novel Anticancer Compounds Nov 8, 2010
Rexahn Awarded Qualifying Therapeutic Discovery Project Grants to Further Develop Anti-Cancer, Depression, and Erectile Dysfunction Treatments Nov 4, 2010
Rexahn Pharmaceuticals Announces Publication of Study on Neuroprotective Effects of Clavulanic Acid Sep 21, 2010
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors Sep 13, 2010
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 12th Annual Healthcare Conference Sep 8, 2010